no more compounding glp 1 drugs Patients struggle as compounded GLP-1 access rapidly shrinks Hims & Hers stock falls

Neutrophil/lymphocyte ratio predicts chemotherapy outcomes in patients with advanced colorectal cancer

injections are preferred for severe deficiency, neurologic involvement, or unreliable absorption

Summary Think of retatrutide and tirzepatide as back-to-back generations of weight-loss peptides

4 dropped due to adverse effects: sleep problems (on DMSA) behavior and some skills worsened (on DMSA) behavior worsened, more self-stimulatory behavior - (on placebo) behavior worsened, some regression (on placebo) In most cases adverse symptoms were temporary and resolved within a week after stopping treatment

Clinicians typically ask patients for subjective feedback: Were you able to achieve an erection adequate for intercourse

DOI: 10.1080/27697061.2022.2159570